期刊文献+

Livin蛋白在原发性肝细胞癌组织中的表达和意义

Expression of livin in hepatocellular carcinoma and its significance
原文传递
导出
摘要 目的探讨凋亡抑制蛋白(inhibitor of apoptosis protein,IAP)Livin在人原发性肝癌(HCC)组织中的表达及其与HCC血管生成的关系。方法应用免疫组织化学法检测42例HCC及对应癌旁组织和12例正常肝组织内Livin的表达情况,观察Livin蛋白与HCC病理学特点及微血管密度(mierovessel density,MVD)之间的关系。结果免疫组织化学(SP)染色结果显示,Livin蛋白在正常肝组织中均不表达,而在42例HCC中的阳性表达率(73.81%)显著高于癌旁组织(4.76%)和正常肝脏组织,有显著统计学意义(x^2=39.13,P〈0.05;x^2=17.89,P〈0.05);Livin蛋白在病理分级Ⅲ~Ⅳ组阳性表达率(85.12%)强度明显高于病理分级Ⅰ~Ⅱ组(53.33%),两者比较差异有显著统计学意义(x^2=4.690,P〈0.05);Livin蛋白在有转移HCC中的阳性表达率(89.47%)明显高于无转移组(60.89%),有统计学意义(x^2=4.404,P〈0.05);Livin蛋白阳性表达HCC中的MVD值明显高于Livin蛋白阴性表达HCC中MVD值(23.56±5.12/17.63±4.86;P〈0.05)。结论Livin蛋白基因在原发性肝癌组织中高表达,提示该基因可能参与了肝癌的发生发展过程;Livin蛋白在HCC组织中的表达明显上调且与血管生成和浸润转移有关。 Objective To explore the expression of livin in hepatocellular carcinoma(HCC). Methods With the method of immunohistochemical staining, specimens from 42 HCC patients and their corresponding para-carcinoma liver tissues and 12 normal liver controls were studied. The relationship between the livin expression and pathological features as well as microvessel density(MVD) was evaluated. Results The expression of livin in the HCC tissues was much higher than that in the corresponding para-carcinoma liver tissues(x^2 = 39.13, P〈0.05)and normal liver tissues(x^2 = 17.89, P〈0.05). Over expression of livin in HCC was related to the invasion of tumor Edmondson grades (X^2 = 4. 690, P〈0.05) and tumor metastasis (X^2 = 4. 404, P〈 0.05). MVD of HCC with positive expression of llvin was much higher than that in HCC with negative expression of livin(P〈0.05). Conclusion The up-regulated expression of the livin protein gene in HCC suggests that livin participates in carcinogenesis. Livin may play a crucial role in the angiogenesis, invasion and metastasis of HCC.
出处 《中华肝胆外科杂志》 CAS CSCD 2008年第8期541-543,共3页 Chinese Journal of Hepatobiliary Surgery
关键词 肝细胞 LIVIN蛋白 微血管密度 免疫组织化学 Carcinoma, hepatocellular Livin Microvessel density Immunohistochemistry
  • 相关文献

参考文献9

  • 1Kasof GM, Gomes BC. Livin. a novel inhibitor of apoptosis protein family member. J Biol Chem, 2001,276:3238-3246.
  • 2Ashhab Y, Alian A, Polliack A, et al. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett, 2001, 485: 56-60.
  • 3Caide LU, Dario CA, Nobuhiko T. Expression of a novel antiapoptosis gene, survivin, correlated with turmor cell apoptosis and P53 accumulation in gastric carcinoma. Cancer Res, 1998, 58: 1808-1812.
  • 4Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new signiticant and independent prognostic indicator in earlystage breast carcinoma. J Natl Cancer Metastasis Rev, 1993, 12: 303-324.
  • 5Song Z, Yao X, Wu M. Direct interaction between surviving and smac is essential for the anti-apoptotie activity of surviving during Taxol-induced apoptosis. J Biol Chem, 2003, 278: 23130-23140.
  • 6Vucic D, Stennieke HR, Pisabarro MT, et al. ML-IAP, a novel inhibitor of apoptosls that is preferentially expressed in human melanomas. Curr Biol, 2000, 10: 1359-1366.
  • 7Gazzaniga P, Gradilone A, Giuliani L, et al. Expression and prognostic significance of livin, survivin and other apoptosis related genes in the progression of superficial bladder cancer. Ann Oncol, 2003,14 : 85-90.
  • 8Cmkovic-Mertens J, Hoppe-Seyler F, Butz K. Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP gene. Oncogene, 2003. 22:8330-8336.
  • 9张华东,袁守军,陈惠鹏.Livin——癌症治疗的新靶点[J].中国药理学通报,2003,19(8):845-847. 被引量:13

二级参考文献9

  • 1Deveraux QL,Reed JC.IAP family proteins-suppressors of apoptosis. Genes Dev, 1999;13(3):239-52.
  • 2Lin JH, Deng G. Huang Q, Morser J, KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun, 2000;279(3) :820-31.
  • 3Vucic D, Stennicke HR, Pisabarro MT et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol, 2000,10(21) : 1359-66.
  • 4Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem, 2001;276(5):3238-46.
  • 5Ashhab Y, Alian A, Polliack A et al. Two splicing variants of a new inhibitor of apoprosis gene with different biological properties and tissue distribution pattern. FEBS Lett, 2001; 495(1-2) :56-60.
  • 6Yang F, Sarangarajan R, Le Poole IC et al. The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity. J Invest Dermatol,2000;114(1) : 157-64.
  • 7Gazzaniga P, Gradilone A, Giuliani L et al. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.Ann Oncol , 2003;14(1):85-90.
  • 8Vucic D, Deshayes K, Ackerly H et al. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis(ML-IAP). J Biol Chem, 2002;277(14) : 12275-9.
  • 9Dias N, Stein CA. Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides.Eur J Phamaceutics , 2002;54(3) :263-9.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部